Abstract
Combination therapies rely on the administration of more than one drug, with independent mechanisms of action, aiming to enhance the efficiency of the treatment. For an optimal performance, the implementation of such therapies requires the delivery of the correct combination of drugs to a specific cellular target. In this context, the use of nanoparticles (NP) as platforms for the co-delivery of multiple drugs is considered a highly promising strategy. In particular, mesoporous silica nanoparticles (MSN) have emerged as versatile building blocks to devise complex drug delivery systems (DDS). This review describes the design, synthesis, and application of MSNs to the delivery of multiple drugs including nucleic acids for combination therapies.
Original language | English |
---|---|
Article number | 2466 |
Pages (from-to) | 1-37 |
Number of pages | 37 |
Journal | Nanomaterials |
Volume | 10 |
Issue number | 12 |
DOIs | |
Publication status | Published - Dec 2020 |
Keywords
- Co-delivery
- Combination therapies
- Drug delivery
- Mesoporous silica
- Nanoparticles
- RNA